Stock Events

Stock Events

Filament Health 

C$0.03
3
+C$0.01+50% Friday 14:54

Statistics

Day High
0.03
Day Low
0.03
52W High
0.09
52W Low
0.02
Volume
666
Avg. Volume
32,919
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

27MarExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
0
0.33
0.67
1
Expected EPS
N/A
Actual EPS
N/A

Financials

-806.82%Profit Margin
Unprofitable
2021
2022
2023
2024
616,000Revenue
-4.97MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FH.NEO. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap606.35M
Compass Pathways focuses on psilocybin therapy for mental health disorders, directly competing in the psychedelic medicine space similar to Filament Health.
AtaiBeckley
ATAI
Mkt Cap1.56B
ATAI Life Sciences works on developing psychedelic and non-psychedelic compounds for mental health disorders, overlapping with Filament Health's market.
GH Research
GHRS
Mkt Cap888.26M
GH Research is involved in the development of psychedelic therapies for treatment-resistant depression, a direct competitor in the psychedelic treatment sector.
Cybin Inc
CYBN
Mkt Cap200.49M
Cybin Inc. develops psychedelic compounds for various psychiatric and neurological conditions, competing in the same new sector as Filament Health.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness focuses on psychedelic production and therapy, directly competing with Filament Health in the integrated health solutions market.
Revive Therapeutics
RVVTF
Mkt Cap4.68M
Revive Therapeutics explores psychedelic-based treatments, particularly focusing on drug development and novel therapies similar to Filament Health.
Noveris Health Sciences
MYCOF
Mkt Cap14.59M
Mydecine Innovations Group focuses on developing and commercializing psychedelic medicines, competing in the same emerging health sector as Filament Health.

About

Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Benjamin Lightburn
Country
CA
ISIN
CA31685W1068

Listings

OTC Link
US
FLHLF

0 Comments

Share your thoughts

FAQ

What is Filament Health stock price today?▼
The current price of FH.NEO is C$0.03 CAD — it has increased by +50% in the past 24 hours. Watch Filament Health stock price performance more closely on the chart.
What is Filament Health stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Filament Health stocks are traded under the ticker FH.NEO.
What is Filament Health revenue for the last year?▼
Filament Health revenue for the last year amounts to 616,000 CAD.
What is Filament Health net income for the last year?▼
FH.NEO net income for the last year is -4.97M CAD.
In which sector is Filament Health located?▼
Filament Health operates in the Health Care sector.
When did Filament Health complete a stock split?▼
Filament Health has not had any recent stock splits.
Where is Filament Health headquartered?▼
Filament Health is headquartered in Burnaby, CA.